Search

Search Constraints

You searched for: Author/Creator Plevris, Nikolas

Search Results

1. Analysis of colectomy rates for ulcerative colitis in pre‐ and postbiological eras in Lothian, Scotland. (17th February 2021)

2. Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease. Issue 2 (3rd July 2019)

3. Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts. (5th June 2021)

4. Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy. Issue 1 (15th May 2020)

5. Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission. Issue 6 (17th October 2018)

6. Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission. Issue 6 (4th May 2019)

8. IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology. Issue 11 (11th July 2019)

9. Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort. Issue 2 (17th February 2023)

10. OWE-04 A capture-recapture study of all-age IBD point prevalence in scotland. Issue 2 (June 2019)